US 10478508
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
granted A61KA61K38/57A61K47/6811
Quick answer
US patent 10478508 (Compositions, methods and uses for alpha-1 antitrypsin fusion molecules) held by The Regents of the University of Colorado, a Body Corporate expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/57, A61K47/6811, A61P, A61P19/06